Welcome to LookChem.com Sign In|Join Free
  • or
Pyrimidine, 4,6-dichloro-5-(1-methylethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

89938-06-7

Post Buying Request

89938-06-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89938-06-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 89938-06-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,3 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 89938-06:
(7*8)+(6*9)+(5*9)+(4*3)+(3*8)+(2*0)+(1*6)=197
197 % 10 = 7
So 89938-06-7 is a valid CAS Registry Number.

89938-06-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,6-dichloro-5-propan-2-ylpyrimidine

1.2 Other means of identification

Product number -
Other names 4,6-dichloro-5-isopropyl-pyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89938-06-7 SDS

89938-06-7Downstream Products

89938-06-7Relevant academic research and scientific papers

STEROID SPARING AGENTS AND METHODS OF USING SAME

-

Page/Page column 537; 557, (2010/02/14)

This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 89938-06-7